Lido Advisors’s CVS Health CVS Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2026
Q2 | $5.79M | Buy |
55,999
+2,123
| +4% | +$190K | 0.02% | 472 |
|
|
2026
Q1 | $3.87M | Buy |
53,876
+2,443
| +5% | +$188K | 0.01% | 519 |
|
|
2025
Q4 | $3.97M | Buy |
51,433
+1,441
| +3% | +$114K | 0.01% | 521 |
|
|
2025
Q3 | $3.77M | Buy |
49,992
+6,859
| +16% | +$470K | 0.01% | 510 |
|
|
2025
Q2 | $2.98M | Buy |
43,133
+11,181
| +35% | +$733K | 0.01% | 492 |
|
|
2025
Q1 | $2.16M | Sell |
31,952
-6,786
| -18% | -$406K | 0.01% | 525 |
|
|
2024
Q4 | $1.74M | Sell |
38,738
-32,715
| -46% | -$1.84M | 0.01% | 555 |
|
|
2024
Q3 | $4.49M | Sell |
71,453
-2,762
| -4% | -$161K | 0.02% | 322 |
|
|
2024
Q2 | $4.38M | Buy |
74,215
+2,444
| +3% | +$153K | 0.02% | 307 |
|
|
2024
Q1 | $5.72M | Buy |
71,771
+11,558
| +19% | +$883K | 0.03% | 262 |
|
|
2023
Q4 | $4.75M | Buy |
60,213
+1,740
| +3% | +$124K | 0.03% | 273 |
|
|
2023
Q3 | $4.08M | Sell |
58,473
-438
| -0.7% | -$31K | 0.03% | 271 |
|
|
2023
Q2 | $4.07M | Buy |
58,911
+1,559
| +3% | +$111K | 0.03% | 250 |
|
|
2023
Q1 | $4.26M | Sell |
57,352
-25,338
| -31% | -$2.12M | 0.04% | 225 |
|
|
2022
Q4 | $7.71M | Buy |
82,690
+4,086
| +5% | +$394K | 0.09% | 121 |
|
|
2022
Q3 | $7.5M | Buy |
78,604
+27,720
| +54% | +$2.74M | 0.09% | 108 |
|
|
2022
Q2 | $4.71M | Sell |
50,884
-2,862
| -5% | -$279K | 0.06% | 138 |
|
|
2022
Q1 | $5.44M | Buy |
53,746
+5,779
| +12% | +$607K | 0.06% | 142 |
|
|
2021
Q4 | $4.97M | Buy |
47,967
+763
| +2% | +$70.5K | 0.05% | 163 |
|
|
2021
Q3 | $4.1M | Buy |
47,204
+17,301
| +58% | +$1.45M | 0.06% | 176 |
|
|
2021
Q2 | $2.5M | Buy |
29,903
+3,464
| +13% | +$284K | 0.03% | 233 |
|
|
2021
Q1 | $1.99M | Buy |
26,439
+2,806
| +12% | +$204K | 0.03% | 226 |
|
|
2020
Q4 | $1.61M | Sell |
23,633
-228
| -1% | -$14.8K | 0.03% | 240 |
|
|
2020
Q3 | $1.39M | Buy |
23,861
+317
| +1% | +$19.7K | 0.04% | 209 |
|
|
2020
Q2 | $1.53M | Sell |
23,544
-7,848
| -25% | -$494K | 0.05% | 187 |
|
|
2020
Q1 | $1.86M | Sell |
31,392
-2,648
| -8% | -$177K | 0.08% | 137 |
|
|
2019
Q4 | $2.53M | Buy |
34,040
+5,208
| +18% | +$366K | 0.1% | 120 |
|
|
2019
Q3 | $1.82M | Buy |
28,832
+1,416
| +5% | +$83.9K | 0.09% | 133 |
|
|
2019
Q2 | $1.49M | Buy |
27,416
+1,807
| +7% | +$97.3K | 0.09% | 134 |
|
|
2019
Q1 | $1.38M | Buy |
25,609
+9,002
| +54% | +$556K | 0.09% | 136 |
|
|
2018
Q4 | $1.09M | Buy |
16,607
+5,888
| +55% | +$440K | 0.11% | 115 |
|
|
2018
Q3 | $843K | Sell |
10,719
-7,161
| -40% | -$512K | 0.08% | 152 |
|
|
2018
Q2 | $1.15M | Buy |
17,880
+4,757
| +36% | +$313K | 0.13% | 98 |
|
|
2018
Q1 | $816K | Sell |
13,123
-754
| -5% | -$54.1K | 0.11% | 124 |
|
|
2017
Q4 | $1.01M | Buy |
13,877
+579
| +4% | +$42.1K | 0.14% | 87 |
|
|
2017
Q3 | $911K | Sell |
13,298
-4,627
| -26% | -$366K | 0.15% | 87 |
|
|
2017
Q2 | $1.44M | Buy |
17,925
+15,251
| +570% | +$1.2M | 0.3% | 45 |
|
|
2017
Q1 | $217K | Buy |
+2,674
| New | +$213K | 0.06% | 205 |
|
|
2016
Q4 | – | Sell |
-3,817
| Closed | -$340K | – | 225 |
|
|
2016
Q3 | $340K | Sell |
3,817
-2,703
| -41% | -$255K | 0.1% | 89 |
|
|
2016
Q2 | $624K | Buy |
6,520
+260
| +4% | +$25.9K | 0.19% | 47 |
|
|
2016
Q1 | $649K | Buy |
+6,260
| New | +$609K | 0.22% | 46 |
|
Other funds holding CVS
Lido Advisors's CVS Position: Q2 2026 in Review
Lido Advisors increased its CVS Health (CVS) stake by 3.9% in Q2 2026, buying an estimated $190K and bringing the position to 55,999 shares worth $5.79M. The position accounts for 0.02% of the portfolio, ranked #472.
Lido Advisors first reported a position in CVS in Q1 2016 and has held it in 41 quarters since. The position peaked at $7.71M in Q4 2022. 2,061 funds tracked by Wall St. Rank hold CVS as of Q2 2026.
- Lido Advisors held 55,999 shares of CVS Health worth $5.79M as of Q2 2026.
- Lido Advisors bought 2,123 CVS Health shares in Q2 2026, an estimated $190K.
- CVS Health made up 0.02% of Lido Advisors's portfolio in Q2 2026, its #472 holding.
- Lido Advisors first reported a position in CVS Health in Q1 2016 and has held it in 41 quarters since.
- Lido Advisors's CVS Health position peaked at $7.71M in Q4 2022.
- 2,061 funds tracked by Wall St. Rank held CVS Health as of Q2 2026.
Based on Lido Advisors's 13F filing for Q2 2026, filed 7 Aug 2026.